Want to see TSE:IFOS full AI Analyst Report?
IFOS Stock Chart & Stats
C$2.44
-C$0.06(-2.56%)
At close: 4:00 PM EDT
C$2.44
-C$0.06(-2.56%)
Day’s Range― - ―
52-Week RangeC$2.15 - C$4.67
Previous CloseN/A
Volume69.14K
Average Volume (3M)57.82K
Market Cap
C$479.16M
Enterprise ValueC$540.28
Total Cash (Recent Filing)C$53.20M
Total Debt (Recent Filing)C$83.87M
Price to Earnings (P/E)6.6
Beta0.28
Next Earnings
Nov 11, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend Yield6.53%
Share Statistics
EPS (TTM)0.27
Shares Outstanding194,780,270
10 Day Avg. Volume46,685
30 Day Avg. Volume57,816
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.95
Price to Sales (P/S)0.73
P/FCF Ratio87.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$3.75Price Target Upside53.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.07
Revenue Forecast (FY)C$641.16M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage gives Itafos meaningful financial flexibility and reduces balance-sheet strain while operating conditions fluctuate. The improvement from a 1.90 debt-to-equity ratio in 2021 also indicates a substantially more resilient capital structure for funding operations and future investment.
Ongoing ProfitabilityPositive earnings and operating profitability show that the phosphate business remains economically viable despite a weaker run-rate than prior years. Continued profitability can support internal funding, preserve lender capacity, and provide a foundation for recovery if market conditions and product mix improve.
Revenue Growth ReboundA return to revenue growth indicates improved top-line momentum after more modest performance in 2024–2025. Sustained sales expansion would strengthen operating scale, support better utilization of phosphate assets, and improve the company’s ability to absorb fixed processing and infrastructure costs.
Bears Say
Negative Free Cash FlowNegative free cash flow means current operations are not fully funding capital needs and other cash requirements. If this persists, Itafos may need to draw on its balance-sheet capacity or seek external funding, reducing flexibility and weakening the quality of reported earnings.
Compressed ProfitabilityMaterial margin compression reduces the earnings cushion available when phosphate pricing, volumes, or operating costs move unfavorably. Even with positive margins today, a lower profitability base makes it harder to sustain returns, fund investment internally, and withstand further pressure on product economics.
Lower Earnings Run-rateThe sharp decline in net income shows that current earnings power is materially below the prior year’s level. A weaker run-rate can constrain reinvestment and cash generation, while also increasing the company’s sensitivity to additional changes in phosphate prices, sales volumes, or operating performance.
Itafos News
IFOS FAQ
What was Itafos’s price range in the past 12 months?
Itafos lowest stock price was C$2.15 and its highest was C$4.67 in the past 12 months.
What is Itafos’s market cap?
Itafos’s market cap is C$479.16M.
When is Itafos’s upcoming earnings report date?
Itafos’s upcoming earnings report date is Nov 11, 2026 which is in 65 days.
How were Itafos’s earnings last quarter?
Itafos released its earnings results on Aug 05, 2026. The company reported -C$0.04 earnings per share for the quarter, missing the consensus estimate of C$0.014 by -C$0.054.
Is Itafos overvalued?
According to Wall Street analysts Itafos’s price is currently Undervalued.
Does Itafos pay dividends?
Itafos pays a Notavailable dividend of C$0.17 which represents an annual dividend yield of 6.53%. See more information on Itafos dividends here
What is Itafos’s EPS estimate?
Itafos’s EPS estimate is 0.01.
How many shares outstanding does Itafos have?
Itafos has 194,780,270 shares outstanding.
What happened to Itafos’s price movement after its last earnings report?
Itafos reported an EPS of -C$0.04 in its last earnings report, missing expectations of C$0.014. Following the earnings report the stock price went down -2.691%.
Which hedge fund is a major shareholder of Itafos?
Currently, no hedge funds are holding shares in TSE:IFOS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Itafos Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$3.75 (53.69% Upside)
C$3.75 (53.69% Upside)
Blogger Sentiment
Neutral
TSE:IFOS Sentiment 100%
Sector Average 61%
Sector Average 61%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.72%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
5.20%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Itafos
Itafos, Inc. engages in the provision of phosphate fertilizers and specialty products. It operates through the following segments: Itafos Conda, Itafos Arraias, Development and Exploration, and Corporate. The Itafos Conda segment produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, and specialty products including ammonium polyphosphate. The Itafos Arraias segment offers single superphosphate (SSP), SSP with micronutrients, premium PK compounds, and excess sulfuric acid. The Development and Exploration segment consists of activities related to Itafos in the following locations: Farim, Paris Hills, Santana, Mantaro, and Araxá. The Corporate segment includes support, administrative, and financing activities. Its Projects include Farim and Santana. The company was founded by Peter J. Marrone and Antenor F. Silva Jr. on July 9, 1999 and is headquartered in Houston, TX.
IFOS Earnings Call
Q2 2026
0:00 / 0:00
IFOS Stock 12 Month Forecast
Average Price Target
C$3.75
▲(53.69% Upside)